Personalized LASIK Surgery Market Updates

Global Personalized LASIK Surgery Market size was valued at USD 2.6 billion in 2023 and is poised to grow from USD 2.72 billion in 2024 to USD 3.93 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

In order to maintain competitiveness, the Global Personalized LASIK Surgery Market participants are heavily active in mergers and acquisitions. The advent of new technologies such as refractive lenticule extraction (ReLEx) and Small Incision Lenticule Extraction (SMILE) with Carl Zeiss' VisuMax laser is projected to create a profitable development platform for this industry. Abbott Molecular Optics and Nidek created products that were both quick and easy to use. AMO's iDesign is a next-generation wavefront approach that is said to produce accurate outcomes with great resolution. 'Alcon Inc. (Switzerland) ', 'Bausch + Lomb (Canada) ', 'Carl Zeiss Meditec AG (Germany) ', 'Johnson & Johnson Vision (USA) ', 'NIDEK CO., LTD. (Japan) ', 'Lumenis Ltd. (Israel) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'Schwind eye-tech-solutions GmbH (Germany) ', 'WaveLight GmbH (Germany) ', 'Technolas Perfect Vision GmbH (Germany) ', 'Haag-Streit Holding AG (Switzerland) ', 'Topcon Corporation (Japan) ', 'Heidelberg Engineering GmbH (Germany) ', 'Optovue, Incorporated (USA) ', 'Abbott Medical Optics (AMO) (USA) ', 'Visionix (France) ', 'iVIS Technologies (Italy) ', 'CSO Costruzione Strumenti Oftalmici (Italy) ', 'OCULUS Optikgeräte GmbH (Germany) ', 'Medmont International Pty Ltd (Australia)'

Highly sophisticated and less invasive vision repair surgical method is a primary driver of the personalized LASIK surgery market. Furthermore, advantages such as cost-effectiveness, fewer side effects, and less problems encourage patients to choose this treatment. Furthermore, rising incidence of refractive diseases such as myopia, hyperopia, and astigmatism, as well as an increase in the number of R&D activities, are likely to fuel market expansion. Furthermore, the increased risk of infection due to the continuous use of contact lenses, the rising frequency of ocular disorders, and the advent of novel ophthalmic technologies are projected to favour the expansion of the personalized LASIK surgery market in the future years.

As customised LASIK surgery is the most recent treatment option for myopia, the demand for LASIK procedures for myopia is increasing. Topography-guided LASIK surgery has been demonstrated in trials to be more successful than other treatments in treating myopia. Dr. A. John Kanellopoulos stated in October 2021 at the European Society of Cataract and Refractive Surgeons that due to eye tracking, cyclorotation compensation, and active centration control in topo-guided LASIK technology, better visual performance than SMILE (Small Incision Lenticule Extraction) was observed over long-term follow-up. Furthermore, in a four-year study comparing the refractive results of LASIK with SMILE, topo-guided LASIK revealed superior visual performance and precision, particularly in very myopic eyes. Such research will almost certainly enhance the use of personalized LASIK operations among myopia-affected populations.

North America's low cost of living makes it a prominent market for personalized LASIK surgery. North America, followed by Europe, is dominating the personalised LASIK surgery market due to their high lifestyle patterns and awareness, as well as the availability of all forms of minimally invasive advanced customised LASIK operations. The presence of important market players in the region, rising awareness levels, and well-established healthcare infrastructure are some of the factors influencing the region's market position. According to National Library of Medicine data updated in November 2021 for LASIK, there are numerous lasers authorised by the US Food and Drug Administration (FDA) for use in LASIK operations. According to the aforementioned source, bespoke LASIK is frequently used.